For the eighth consecutive year, Samjin Pharmaceutical's antipyretic analgesic Geworin won the grand prize in the analgesics category at the Brand Customer Loyalty Awards.
The 2023 Brand Customer Loyalty survey utilizes the Global Customer Loyalty Index (BCLI) to assess consumers' emotional and attitudinal loyalty toward brands and switching intentions.
Celebrating the 44th anniversary of its launch this year, Geworin remains a consumer favorite choice for its proven fast-acting efficacy. The Geworin brand has grown solidly to include Geworin Tablets, Geworin V Tablets, and Geworin Cooldown Tablets.
Mr. Choi Yong-Ju, CEO of Samjin Pharmaceutical said, "As the Korea's leading painkiller brand, we will strive to reciprocate by making good quality medicines."
[WIKI KOREA=Cho Eun, Reporter]
choeun@wikileaks-kr.org